Drug Claims Violate FCA, Ex-Pfizer Exec Tells 1st Circ.
A former Pfizer Inc. executive urged the First Circuit on Thursday to revive his False Claims Act suit against the drugmaker over its human growth hormone Genotropin, arguing that the disputed...To view the full article, register now.
Already a subscriber? Click here to view full article